Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: TH1NG - Targets positive result in FY 2025

Th1ng

Redeye revises our forecast and fair value range in light of TH1NG’s Q3’23 report. Although the top-line was slightly weaker than anticipated, a reduced cost base offset this, resulting in better-than-expected EBITDA. Business momentum remains robust, and TH1NG’s product portfolio experienced substantial growth with the IIOTE acquisition during the quarter. However, given the seasonality effects, we are cautious to extrapolate the stronger-than-expected margins and results observed in Q3’23.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


TH1NG - Targets positive result in FY 2025

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.